Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Quadrivalent meningococcal conjugate vaccines

Registered for use in people aged 9 months to 55 years.

MenACWY-D — quadrivalent meningococcal (serogroups A, C, W-135, Y)–diphtheria toxoid conjugate vaccine

Each 0.5 mL monodose vial contains:

  • 4 µg meningococcal polysaccharide serogroup A
  • 4 µg meningococcal polysaccharide serogroup C
  • 4 µg meningococcal polysaccharide serogroup W-135
  • 4 µg meningococcal polysaccharide serogroup Y
  • 48 µg diphtheria toxoid protein

For full details, refer to the product information and consumer medicine information sheets for Menactra vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018